Michael Kavanagh
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Michael Kavanagh is President, CEO & Executive Director at Nanosonics Ltd. since 2013.
Mr. Kavanagh was Senior Vice President-Global Marketing at Cochlear Ltd. from 2003 to 2013.
Mr. Kavanagh earned an MBA from The University of Queensland and completed undergraduate studies at University College Dublin.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NANOSONICS LIMITED 0,48 % | 11/12/2025 | 1 432 788 ( 0,48 % ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NANOSONICS LIMITED | Directeur Général | 21/10/2013 |
| Sociétés | Poste | Fin |
|---|---|---|
| COCHLEAR LIMITED | Sales & Marketing | 01/10/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Nanosonics Ltd.
Nanosonics Ltd. Medical SpecialtiesHealth Technology Engages in the research, development and commercialization of infection control and decontamination products and related technologies | Health Technology |
Cochlear Ltd.
Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national